|
ECHAMP response
|
to the HMPWG public consultation "4th List of First Safe Dilutions (FSD)" |
PDF
(264.3 KB)
|
May 07, 2018
|
|
ECHAMP response
|
to the HMPWG public consultation "sixth list entries of stocks for which homeopathic use is justified" |
PDF
(253.8 KB)
|
Mar 28, 2018
|
|
ECHAMP response
|
to the HMPWG public consultation "Preamble to the Consolidated list of stocks for which homeopathic use is justified" |
PDF
(403.3 KB)
|
Mar 28, 2018
|
|
ECHAMP response
|
to the draft guideline on non-clinical documentation in applications for marketing authorisation/registration of well-established and traditional herbal medicinal products - Revision 1 (EMEA/HMPC/32116/2005 Rev.1) |
PDF
(151.9 KB)
|
Nov 20, 2017
|
|
ECHAMP response
|
to the HMPWG public consultation "3rd List of First Safe Dilutions (FSD)" |
PDF
(318.2 KB)
|
Oct 09, 2017
|
|
ECHAMP response
|
to the public consultation on the structures of excise duties
applied to alcohol and alcoholic beverages |
PDF
(219.0 KB)
|
Jun 14, 2017
|
|
ECHAMP response
|
to the HMPWG public consultation "2nd List of First Safe Dilutions (FSD)" |
PDF
(515.0 KB)
|
May 15, 2017
|
|
ECHAMP response
|
to the public consultations on possible activities under a "Commission Communication on a One Health Action Plan to support Member States in the fight against Antimicrobial Resistance (AMR)" |
PDF
(160.9 KB)
|
Mar 03, 2017
|
|
ECHAMP response
|
to the HMPWG public consultation "fifth list entries of stocks for which homeopathic use is justified" |
PDF
(688.7 KB)
|
Feb 24, 2017
|
|
ECHAMP response
|
to the HMPWG public consultation "Questions and answers document on HMPWG quality of homeopathic medicinal product (Q 1-3)" |
PDF
(785.1 KB)
|
Feb 24, 2017
|
|
ECHAMP response
|
to the implementation strategy of ICH Q3D guideline, EMA Draft 1 July 2016 |
PDF
(355.7 KB)
|
Aug 03, 2016
|
|
ECHAMP response
|
Opinion of the Expert Platform of Effective Ways of Investing in Health |
PDF
(245.7 KB)
|
Jul 14, 2016
|
|
ECHAMP response
|
to the "fourth list entries of stocks for which homeopathic use is justified” |
PDF
(301.6 KB)
|
Feb 16, 2016
|
|
ECHAMP response
|
to the "Preamble to the consolidated list of justified homeopathic
stocks" |
PDF
(181.1 KB)
|
Feb 16, 2016
|
|
ECHAMP response
|
to Better Regulation Agenda |
PDF
(393.9 KB)
|
Oct 12, 2015
|
|
ECHAMP response
|
on conference on '50 Years of EU Pharma legislation: Achievements and future perspectives' |
PDF
(486.2 KB)
|
Aug 08, 2015
|
|
ECHAMP response
|
to the 'External Study Report on the Availability of Medicinal Products for Human Use,’ by Matrix Insight |
PDF
(432.3 KB)
|
Dec 17, 2014
|
|
ECHAMP response
|
to public Consultation on Patient Safety and Quality of Care |
PDF
(232.8 KB)
|
Sep 16, 2014
|
|
ECHAMP response
|
to the communication from the Commission on effective, accessible and resilient health systems |
PDF
(336.7 KB)
|
Jul 08, 2014
|
|
ECHAMP response
|
to Staff Working Document 'Investing in Health' Accompanying the Document Towards Social Investment for Growth |
PDF
(507.8 KB)
|
May 29, 2013
|